Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Non-metastatic and metastatic Castration-Resistant and Castration-Sensitive Prostate Cancer.
Relapsed/refractory Multiple Myeloma, Diffuse Large B-Cell Lymphoma, Small Cell Lung Cancer, or Acute Lymphoblastic Leukemia.
Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.
Relapsed/refractory Multiple Myeloma, Diffuse Large B-Cell Lymphoma, Small Cell Lung Cancer, or Acute Lymphoblastic Leukemia.
Treatment of anemia in cancer patients receiving concurrent myelosuppressive chemotherapy.
Treatment of anemia in cancer patients receiving concurrent myelosuppressive chemotherapy.
KRAS wild-type metastatic colorectal cancer (mCRC) in combination with chemotherapy or as a single agent; locally or regionally advanced squamous cell carcinoma of the head and neck (SCCHN) in combination with radiation.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Ovarian Cancer, Kaposi Sarcoma, and Lymphomas.
Approved for use in oncology care according to FDA-approved indications.
Non-metastatic and metastatic Castration-Resistant and Castration-Sensitive Prostate Cancer.
EGFR-mutated Non-Small Cell Lung Cancer (NSCLC).